Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
Colchicine Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022 20 5
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Budesonide Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/31/2021 1 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Acetylsalicylic acid Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 6 0
Doxycycline Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/14/2021 6 0
Montelukast Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/23/2021 5 0
Excel (.xslx) CSV (.csv)